- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05270291
Infectious Etiology of Vomiting in Children With Presumed Acute Gastroenteritis
Infectious Etiology of Vomiting in Children With Presumed Acute Gastroenteritis in the Absence of Diarrhea
In children with acute gastroenteritis (AGE), vomiting often precedes diarrhea. To establish the diagnosis of AGE, enteropathogen detection typically relies on diarrheal stool samples. However, testing requires sufficient stool sample, which may not be easily available. Recent studies suggest that in children presenting to emergency departments with presumed AGE with isolated vomiting, an enteropathogen can be identified using rectal swabs and molecular diagnostic tests. The rate of enteropathogen detection in children with isolated vomiting due to AGE may differ in various populations. Using rectal swabs and molecular diagnostic tests, we plan to assess the proportion of children with isolated vomiting with presumed AGE in whom an enteropathogen can be identified.
This will be a prospective cohort study. Children younger than 5 years with presence of ≥3 episodes of vomiting due to presumed AGE, lasting no longer than 7 days before enrolment, will be recruited. A total of 198 participants will be recruited and a rectal swab will be collected. The participants will be contacted 14 days after enrollment to complete a survey regarding symptoms experienced during that period and to identify any additional clinical care.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Anticipated)
Contacts and Locations
Study Contact
- Name: Aleksandra Cepińska, MD
- Phone Number: 223179444
- Email: ocepinska@gmail.com
Study Contact Backup
- Name: Aleksandra Cepińska
Study Locations
-
-
Mazovian
-
Warsaw, Mazovian, Poland, 02-091
- Recruiting
- Medical University of Warsaw
-
Contact:
- Aleksandra Cepińska, MD
- Phone Number: 223179444
- Email: ocepinska@gmail.com
-
Contact:
- Maciej Kołodziej, PhD
- Phone Number: 223179444
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- age 0-5-year-old
- presence of ≥3 episodes of vomiting due to presumed AGE at inclusion
- <7 days of symptoms at the time of inclusion
- signed written informed consent
Exclusion Criteria:
- anticipated inability to complete 14 days follow-up
- history of neutropenia (as rectal swabs are contraindicated)
- critically ill status requiring urgent medical intervention
- inability to provide a rectal swab for testing
- chronic gastrointestinal tract disorders such as inflammatory bowel disease, cystic fibrosis, coeliac disease
- immunodeficiency
Study Plan
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Prospective
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
The proportion of children with isolated vomiting with presumed AGE in whom an enteropathogen can be identified.
Time Frame: immediately after the procedure
|
immediately after the procedure
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Types of pathogens detected based on presenting symptoms
Time Frame: immediately after the procedure
|
immediately after the procedure
|
The proportion of children with isolated vomiting with alternative diagnosis
Time Frame: immediately after procedure
|
immediately after procedure
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Isolated vomiting etiology
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Vomiting
-
Instituto Materno Infantil Prof. Fernando FigueiraUniversidade Federal de PernambucoCompleted
-
MonoSol RxCompletedNausea With Vomiting Chemotherapy-Induced | Nausea and Vomiting, PostoperativeIndia
-
GlaxoSmithKlineCompletedPostoperative Nausea and Vomiting | Nausea and Vomiting, PostoperativeUnited States, Spain, Philippines, Israel, Hong Kong, Thailand, United Kingdom, Hungary, Slovenia, Norway, Denmark
-
Hoffmann-La RocheCompletedPost-Operative Nausea and VomitingUnited States
-
Cairo UniversityUnknownPost Operative Nausea and VomitingEgypt
-
Yonsei UniversityCompletedPost Operative Nausea and VomitingKorea, Republic of
-
Oregon Health and Science UniversityCompletedPostoperative Vomiting and NauseaUnited States
-
AccentureCompletedPost-Operative Nausea and Vomiting (PONV)Australia
-
Methodist Health SystemRecruitingNausea, Postoperative | Vomiting, PostoperativeUnited States
-
GlaxoSmithKlineCompletedPostoperative Nausea and Vomiting | Nausea and Vomiting, PostoperativeUnited States, Hungary, Canada, Spain, Belgium, Germany
Clinical Trials on rectal swab
-
Assistance Publique Hopitaux De MarseilleCompleted
-
University of LuebeckUniversity Hospital Tuebingen; University of Giessen; University Hospital Freiburg and other collaboratorsRecruiting
-
Assistance Publique Hopitaux De MarseilleCompleted
-
Centre Hospitalier Universitaire de BesanconCompletedDrug Resistance, BacterialFrance
-
Academisch Medisch Centrum - Universiteit van Amsterdam...Unknown
-
Meridian Bioscience, Inc.Active, not recruitingCarbapenem-Resistant EnterobacteriaceaeUnited States, Canada
-
Rambam Health Care CampusWithdrawnGBS | Group B Streptococcal Infection
-
Assistance Publique - Hôpitaux de ParisParis-Saclay UniversityRecruitingTraumatic Brain Injury | Multiple TraumaFrance
-
Assistance Publique - Hôpitaux de ParisRecruitingBetalactams HypersensitivityFrance
-
Assistance Publique - Hôpitaux de ParisInstitut National de la Santé Et de la Recherche Médicale, France; Institut... and other collaboratorsCompletedCOVID-19 InfectionFrance